Page last updated: 2024-08-24

tenofovir and Kidney Diseases

tenofovir has been researched along with Kidney Diseases in 175 studies

Research

Studies (175)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	48 (27.43)	29.6817
2010's	113 (64.57)	24.3611
2020's	14 (8.00)	2.80

Authors

Authors	Studies
Barbini, B; Burling, K; Campbell, L; Cromarty, B; Hamzah, L; Johnson, M; Jones, R; Post, FA; Samarawickrama, A; Williams, D; Winston, A	1
Distenhreft, JIQ; Fioroti, CEA; Lacchine, K; Luchi, WM; Paulino, BB; Ramos, DR; Seguro, AC	1
Cho, JY; Choi, D; Choi, DL; Hong, G; Hwang, S; Kang, KJ; Kim, BW; Kim, DS; Kim, JM; Kim, MS; Lee, J; Lee, JG; Lee, KW; Moon, JI; Nah, YW; Ryu, JH; You, YK; Yu, HC	1
Sluis-Cremer, N	1
Chetty, M; De Sousa Mendes, M	1
Avataneo, V; Bonora, S; Calcagno, A; Cusato, J; Di Perri, G; DʹAvolio, A; Marinaro, L	1
Bailey, AC; Barbini, B; Burling, K; Campbell, L; Hamzah, L; Ibrahim, F; Jones, R; Musso, CG; Post, FA; Williams, D	1
Bajpai, P; Jain, A; Maheshwari, PK	1
Adoua Doukaga, T; Axel Aloumba, G; Bienvenue Ossibi Ibara, R; Boumandoki, P; Diafouka, M; Herbas Ekat, M; Mahambou-Nsonde, D; Obengui, P; Roger Nzounza, P; Seydi, M; Tidiane Ndour, C	1
Chadwick, D; Moss, D; Neary, M; Olagunju, A; Owen, A; Phillips, R; Sarfo, F	1
Ahamed, J; Choi, ME; Elhadad, S; Fung, KM; Gostynska, S; Laurence, J; Terry, H; Varshney, R; Yu, Z	1
Béguelin, C; Bernasconi, E; Boillat-Blanco, N; Chave, JP; Doco-Lecompte, T; Fehr, J; Furrer, H; Günthard, HF; Rauch, A; Schmid, P; Stöckle, M; Surial, B; Walti, LN; Wandeler, G	1
Chainuvati, S; Chotiyaputta, W; Kiattisunthorn, K; Poosanasuwansri, K; Tanwandee, T	1
Dickens, C; Duarte, R; Hassan, MO; Lasisi, AO; Mabayoje, VO; Naicker, S	1
Abdel Alem, S; Atef, M; Hamed, M; Saber, M; Salama, R; Yosry, A; Yousof, H; Zayed, N	1
Bayerri, CR; Payne, BAI; Price, DA; Samuels, R; Sayer, JA	1
Chen, J; Chen, L; Cheng, L; Chi, W; Deng, H; Huo, Y; Lan, Z; Liu, X; Siegenthaler, JA; Song, W; Sun, K; Xu, L; Zhao, X	1
Boulle, A; Cohen, K; Davies, MA; De Waal, R; Fox, MP; Igumbor, EU; Maartens, G; Stinson, K	1
Atzori, C; Clementi, EGI; Falvella, FS; Galli, M; Giacomelli, A; Meraviglia, P; Oreni, ML; Rusconi, S; Salvaggio, SE	1
Gallagher, A; Gracey, DM; Quan, D	1
Chen, M; Chow, EP; Fairley, CK; Medland, NA; Read, TR; Walker, RG	1
Akpomiemie, G; Arulappan, N; Chersich, MF; Majam, M; Mashabane, N; Moorhouse, M; Venter, WDF	1
Atta, MG; Choi, MJ; Fine, D; McMahon, BA; Novick, TK; Rosenberg, AZ	1
Chesire, E; Kigen, G; Koech, M; Some, F	1
Gatanaga, H; Kawasaki, Y; Kikuchi, Y; Mutoh, Y; Nishijima, T; Oka, S; Tomonari, K	1
Asriel, B; Chan, L; Eaton, EF; Wyatt, CM	1
Amet, S; Deray, G; Isnard-Bagnis, C; Loens, C; Tourret, J	1
Appiah, LT; Beloukas, A; Chadwick, D; Geretti, AM; Phillips, RO; Post, F; Ruggiero, A; Sarfo, FS; Smith, C; Stockdale, AJ; Villa, G	1
Clotet, B; Negredo, E	1
Bennett, M; Coca, SG; Defechereux, P; Gandhi, M; Glidden, DV; Grant, RM; Jotwani, V; Liu, A; Mehrotra, M; Parikh, CR; Scherzer, R; Shlipak, MG	1
Firląg-Burkacka, E; Grycner, E; Horban, A; Kowalska, JD; Matłosz, B; Pietraszkiewicz, E	1
Kingdon, E; Richardson, D; Scott, J; Williams, D	1
Abraham, P; Isaac, B; Ramamoorthy, H; Selvakumar, D	2
Ahn, A; Bae, HS; Chang, M; Fong, TL; Lee, BT; Lim, C; Tien, A	1
Bae, SH; Chang, UI; Cho, EY; Choi, JY; Choi, SW; Han, NI; Jang, JW; Kim, CW; Kim, HY; Kim, SG; Kim, SH; Kim, YS; Kwon, JH; Lee, BS; Lee, HL; Lee, SW; Lee, TH; Nam, SW; Song, DS; Song, MJ; Yang, JM; Yoon, SK; You, CR	1
Maponga, CC; Morse, GD; Mtisi, TJ; Ndhlovu, CE	1
Bąkowska, E; Firląg-Burkacka, E; Horban, A; Kowalska, JD; Matłosz, B; Vassilenko, A	1
Gatanaga, H; Kikuchi, Y; Komatsu, H; Nishijima, T; Oka, S; Shimbo, T; Takano, M; Tanuma, J; Teruya, K; Tsukada, K	1
Kanjanabuch, T; Suankratay, C; Woratanarat, K	1
Funk, EK; Heytens, L; Kohli, A; Kottilil, S; Kwan, R; Masur, H; Nelson, A; Polis, MA; Shaffer, A; Shivakumar, B; Sneller, M	1
Cao, Y; Cui, Q; Han, Y; Li, T; Li, Y; Song, X; Xie, J; Zhang, L; Zhu, T	1
Foisy, MM; Hills-Nieminen, C; Hughes, C; Joffe, AM; Singh, AE	1
Bailly, F; Brochier, C; Cotte, L; Le Pogam, MA; Maynard, M; Miailhes, P; Okon, JB; Pradat, P; Trolliet, P; Zoulim, F	1
Ahmed-Jushuf, I; Arumainayagam, J; Carlin, EM; Chandramani, S; Das, S; Ghanem, M; Kumari, B; Pammi, M; Riddell, L	1
Arai, M; Satoh, M; Tanaka, H; Tomoda, Y; Wada, T; Yago, K	1
Cattaneo, D; Clementi, E; Giacomet, V; Manfredini, V; Nannini, P; Ramponi, G; Viganò, A; Zuccotti, GV	1
Bekker, LG; Kamkuemah, M; Kaplan, R; Myer, L	1
Buyze, J; Lynen, L; Phirum, L; Thai, S; van Griensven, J	1
Graber, P; Kalbermatter, S; Kiss, D; Koenig, KF; Menter, T	1
Jabłonowska, E; Piekarska, A; Wójcik, K	1
Lundgren, JD; Mocroft, A; Ryom, L	1
Fung, J; Lai, CL; Seto, WK; Yuen, MF	1
Cattaneo, D; Fucile, S; Gervasoni, C; Milazzo, L; Pezzani, D	1
Currier, J; Hogg, E; Hosseinipour, M; Hughes, MD; Lockman, S; Mulenga, L; Mwafongo, A; Nkanaunena, K; Samaneka, W; Siika, A; Zheng, Y	1
Bosch, ME; Burger, DM; Ezinga, M; van der Ven, AJ; Wetzels, JF	1
Campbell, LJ; Chadwick, D; Fisher, M; Gilson, R; Hamzah, L; Hay, P; Hill, T; Johnson, M; Jones, R; Jose, S; Leen, C; Nelson, M; Nitsch, D; Post, FA; Sabin, CA; Walsh, J	1
Anderson, AM; Ebrahimi, R; Flaherty, JF; Fortin, C; Fralich, T; Graham, H; Gupta, SK; Kalayjian, RC; Rachlis, A; Scharen-Guivel, V; Wyatt, CM	1
Bele, V; Bhagani, S; Dabhade, D; Johnson, M; Joshi, K; Makane, A; Pujari, SN; Smith, C; Youle, M	1
Dashti-Khavidaki, S; Jafari, A; Khalili, H	1
Andrade, L; Canale, D; de Bragança, AC; Gonçalves, JG; Sanches, TR; Seguro, AC; Shimizu, MH; Volpini, RA	1
Aiestarán, A; Bonet, J; Bonjoch, A; Clotet, B; Echeverría, P; Juega, J; Negredo, E; Pérez, V; Pérez-Alvarez, N; Puig, J; Romero, R	1
De Baetselier, I; Deese, J; Lombaard, J; Malahleha, M; Mandala, J; Manongi, R; Nanda, K; Owino, F; Taylor, D; Van Damme, L; Wang, M	1
Badiou, S; Bargnoux, AS; Cournil, A; Cristol, JP; Dupuy, AM; Fernandez, C; Peyriere, H; Reynes, J; Toubal, S	1
Cherian, AO; Mitra, S; Priscilla, R; Rajeev, K; Rajkumar, S; Sauradeep, S	1
Duim, AR; Rijnders, BJ; Rokx, C; van Gorp, EC	1
Foster, C; Lim, Y; Lyall, H	1
Chang, KC; Chen, CH; Chiu, KW; Chou, YP; Hu, TH; Hung, CH; Lee, CM; Lin, MT; Lu, SN; Tsai, MC; Tseng, PL; Wang, JH; Yen, YH	1
Gatanaga, H; Hayashida, T; Kurosawa, T; Nishijima, T; Oka, S; Tanaka, N	1
Badiou, S; Casanova, ML; Cournil, A; Cristol, JP; Peyriere, H; Reynes, J	1
Boeker, K; Eisenbach, C; Felten, G; Hartmann, H; Heyne, R; Hueppe, D; John, C; Krause, W; Leuschner, M; Loehr, HF; Mauss, S; Petersen, J; Ruppert, S; Schiffelholz, W; Schlaak, J; Trautwein, C; Trein, A; Warger, T; Wiese, M	1
Bedu-Addo, G; Chadwick, DR; Kirk, ES; Owusu, AL; Owusu, D; Parris, V; Phillips, R; Sarfo, FS	1
Kittitrakul, C; Leowattana, W; Nontprasert, A; Phumratanaprapin, W; Poovorawan, K; Sriboonvorakul, N; Tangkijvanich, P; Thu, AM; Wilairatana, P	1
Horn, TH; Paltiel, AD; Walensky, RP	1
Bañón, S; Casado, JL; del Rey, JM; Guzman, P; Liaño, F; Santiuste, C; Serna, J; Tenorio, M	1
Effa, EE; Okonkwo, RI; Weidmann, AE	1
Likanonsakul, S; Nakayama, EE; Nitiyanontakij, R; Prasithsirikul, W; Sangsajja, C; Shioda, T; Suntisuklappon, B	1
Bourlière, M; Cadranel, JF; Causse, X; Consoli, SM; Dumortier, J; Hézode, C; Larrey, D; Libert, O; Marcellin, P; Ouzan, D; Pageaux, GP; Pauwels, A; Pétour, P; Riachi, G; Roche, B; Stern, C; Tilliet, V; Truchi, R; Zarski, JP; Zoulim, F	1
Amer, H; Berg, ML; Cummins, NW; Marcelin, JR; Rizza, SA; Tan, EM	1
Bañón, S; Caballero, C; Casado, JL; Gomez, A; Moreno, S; Perez-Elías, MJ; Rey, JM; Rosillo, M; Santiuste, C; Vazquez, M	1
Bañón, S; Casado, JL; Del Rey, JM; Liaño, F; Moreno, A; Moreno, S; Perez-Elías, MJ; Rodriguez, M; Santiuste, C	1
Chong, Y; Huang, M; Jie, Y; Li, X; Lin, G; Shi, H; Wu, Y	1
Aloy, B; Deray, G; Isnard-Bagnis, C; Tourret, J	1
Barber, TJ; Girometti, N; Jones, R; Levy, J; McCormack, S; Sullivan, A	1
Avihingsanon, A; Chaiwarith, R; Choi, JY; Ditangco, R; Jiamsakul, A; Kamarulzaman, A; Kantipong, P; Kiertiburanakul, S; Kumarasamy, N; Lee, MP; Makane, A; Merati, TP; Mustafa, M; Ng, OT; Nguyen, KV; Pham, TT; Pujari, S; Ratanasuwan, W; Saphonn, V; Sim, BL; Sohn, AH; Tanuma, J; Wong, WW; Yunihastuti, E; Zhang, F	1
Collado Borrell, R; Gutiérrez García, ML; López Centeno, B; Pérez Encinas, M; Sanmartin Fenollera, P	1
He, J; Li, K; Li, W; Ning, HB; Shang, J; Zeng, YL	1
Bedimo, R; Myers, J; Rosenblatt, L	1
Post, FA	1
Coumbis, J; Myers, J; Nkhoma, ET; Rosenblatt, L; Villasis-Keever, A	1
Koh, HM; Suresh, K	1
Bailey, A; Booth, JW; Chadwick, DR; Hamzah, L; Hay, P; Hegazi, A; Hendry, BM; Johnson, M; Jones, R; Jose, S; Levy, JB; Post, FA; Rayment, M; Sabin, CA; Williams, DI	1
Atta, MG; Estrella, MM; Fine, DM; Lucas, GM; Mcfall, AM; Schwartz, GJ; Sheets, KM; Zook, K	1
Andrade, L; Libório, AB; Pereira, LV; Sanches, TR; Seguro, AC; Shimizu, MH	1
Crane, HM; Harrington, RD; Kestenbaum, B; Kitahata, MM	1
Deray, G; Hawkins, T; Szczech, L; Winston, J; Wyatt, C; Young, B	1
Azanza, JR; García Quetglas, E; Gómez-Giu, A; Sádaba, B	1
Fiorante, S; Pulido, F	1
Barril Cuadrado, G; de Los Santos Gil, I	1
Mallolas, J	1
Hanabusa, H; Kinai, E	1
Hernández, JM; Jarilla, F; Romero, E	1
Connolly, JO; Copas, A; Edwards, SG; Hall, AM; Johnson, MA; Madge, S; Nair, D; Williams, IG; Woodward, CL	1
Brooks, JT; Buchacz, K; Moorman, A; Wood, KC; Young, B	1
Gallant, JE; Moore, RD	1
Labarga, P; Rodriguez-Novoa, S; Soriano, V	1
Agarwala, R; Cheng, JT; Herlitz, LC; Mohan, S	1
Carr, A; van Agtmael, MA; Wever, K	1
Flandre, P	1
Albalate, M; Barreiro, P; Bonora, S; D'avolio, A; Di Perri, G; Labarga, P; Rodríguez-Nóvoa, S; Siccardi, M; Solera, C; Soriano, V; Vispo, E	1
Alvarez, E; Labarga, P; Rodriguez-Nóvoa, S; Soriano, V	1
Barahona, I; Brodine, S; Crum-Cianflone, N; Ganesan, A; Medina, S; Riddle, M; Teneza-Mora, N	1
Cooper, RD; Keiser, P; Naicker, S; Smith, N; Tonelli, M; Wiebe, N	1
Figueras, C; Fortuny, C; Garcia, L; Martín-Nalda, A; Melendo, S; Mellado, MJ; Navarro, ML; Noguera-Julian, A; Soler-Palacín, P; Uriona, S	1
Cooper, RD; Tonelli, M	1
Campbell, LJ; Hamzah, L; Post, FA	1
Connolly, JO; Hall, AM; Hendry, BM; Nitsch, D	1
Calza, L; Colangeli, V; Manfredi, R; Piergentili, B; Tedeschi, S; Trapani, F; Viale, P	1
Gracey, D; MacLeod, C; McKenzie, P; Post, J	1
Harbord, N	1
Albalater, M; Back, DJ; Bonora, S; Di Perri, G; Hopper-Borge, E; Khoo, S; Labarga, P; Liptrott, NJ; Owen, A; Pirmohamed, M; Pushpakom, SP; Rodríguez-Nóvoa, S; Soriano, V	1
Koole, O; Lynen, L; Sopheak, T; van Griensven, J; Verpooten, GA	1
Allavena, C; Dejesus, E; Fernandez Garcia, E; Fisher, M; Hardy, WD; Jackson, AG; Jayaweera, DT; Katlama, C; Mauss, S; Moyle, GJ; Raffi, F; Reiss, P; Slama, L; van Eeden, A; Vrouenraets, SM; Wit, FW	1
Bando, H; Kasai, D; Kushida, H; Kuwahara, T; Nishida, Y; Ogawa, Y; Shirasaka, T; Taniguchi, T; Uehira, T; Watanabe, D; Yagura, H; Yajima, K; Yonemoto, H; Yoshino, M	1
Gibb, DM; Gilks, CF; Grosskurth, H; Hakim, J; Kityo, C; Mambule, I; Munderi, P; Reid, A; Ssali, F; Stöhr, W; Walker, AS	1
Pletz, MW; Schleenvoigt, BT; Stallmach, A	1
Angarano, G; Bellacosa, C; Graziano, G; Maggi, P; Montinaro, V; Pietanza, S; Strippoli, GF; Volpe, A	1
Bugeja, A; Gupta, A; Kirpalani, D	1
Lescure, FX; Plaisier, E; Ronco, P	1
Amodio, D; Baldassari, S; Bernardi, S; Cotugno, N; Palma, P; Pontrelli, G; Tchidjou, HK; Zangari, P	1
Islam, FM; Jansson, J; Wilson, DP; Wu, J	1
Baqai, S; Clark, MD; Gish, RG; Kane, SD; Mangahas, MF; Shaw, RE	1
Chianura, L; Errante, I; Moioli, MC; Orcese, C; Orso, M; Puoti, M; Rossotti, R; Schiantarelli, C; Schlacht, I; Travi, G; Vigo, B; Villa, MR; Volonterio, A	1
Hall, AM	1
Bonjoch, A; Clotet, B; Echeverría, P; Estany, C; Negredo, E; Perez-Alvarez, N; Puig, J	1
Gatanaga, H; Hayashida, T; Higasa, K; Komatsu, H; Nishijima, T; Oka, S; Takano, M; Tsuchiya, K	1
Borderi, M; Calza, L; Colangeli, V; Di Bari, MA; Magistrelli, E; Manfredi, R; Salvadori, C; Trapani, F; Viale, P	1
Baril, JG; Dufresne, S; Laprise, C; Trottier, H	1
Coffin, CS; Fung, SK; Ma, MM	1
Coca, S; Perazella, MA	1
Antoniou, T	1
Cheng, A; Deray, G; Hulot, JS; Isnard-Bagnis, C; Izzedine, H; Jais, CK; Launay-Vacher, V; Vittecoq, D	1
Gutiérrez, F; Masiá, M; Padilla, S; Pascual, J; Ramos, JM	1
Peraire, J; Ribera, E; Richart, C; Sauleda, S; Saumoy, M; Vea, AM; Vidal, F; Viladés, C	1
Perazella, MA; Rifkin, BS	1
Berger, F; Mauss, S; Schmutz, G	1
Cheng, A; Deray, G; Gallant, JE; Hulot, JS; Izzedine, H; Launay-Vacher, V; Staszewski, S; Vittecoq, D	1
Gallant, JE; Keruly, JC; Moore, RD; Parish, MA	1
Mallal, S; Nolan, D; Reiss, P	1
Antoniou, T; Chirhin, S; Gough, K; Govan, V; Loutfy, M; Raboud, J; Rachlis, A; Yoong, D	1
Gupta, SK	1
Bogner, JR; Crispin, A; Goebel, FD; Jülg, BD	1
Cánovas, V; Gutiérrez, F; Masiá, M; Orozco, C; Padilla, S	1
Hussain, S; Khayat, A; Rathore, MH; Tolaymat, A	1
Cirino, CM; Kan, VL	1
Shepp, DH; Winston, J	1
Panda, A	1
Bonfanti, P; Carradori, S; De Socio, G; Grosso, C; Madeddu, G; Marconi, P; Melzi, S; Mura, MS; Palvarini, L; Penco, G; Quirino, T; Ricci, E; Rossella, E	1
Lok, AS; Tan, J	1
Gallant, JE; Klotman, PE; Sax, PE	1
Baskin, CH; Gitman, MD; Hirschwerk, D; Singhal, PC	1
Aboulker, JP; Chazallon, C; Gérard, L; Girard, PM; Piketty, C; Taburet, AM	1
Bischofberger, N; Chen, SS; Clotet, B; Cooper, DA; Curtis, S; Gazzard, B; Katlama, C; Lange, J; Lazzarin, A; Montaner, JS; Nelson, MR; Rooney, JF; Schewe, K; Smith, S; Wyatt, C	1
Bonfanti, P; Carradori, S; De Socio, GV; Grosso, C; Landonio, S; Madeddu, G; Marconi, P; Melzi, S; Miccolis, S; Mura, MS; Penco, G; Quirino, T; Ricci, E; Rosella, E	1
Christen, A; Furrer, H; Fux, CA; Mohaupt, MG; Zgraggen, S	1
Beretta, S; Borgonovo, S; Cafarelli, L; Giacomet, V; Martelli, L; Mora, S; Rombolà, G; Viganò, A; Zuccotti, GV	1
de Silva, TI; Dockrell, DH; Griffin, MD; Post, FA	1
Blanchet, F; Duval, X; Essig, M; Gervais, A; Iordache, L; Kaied, FA; Leport, C; Longuet, P; Peytavin, G	1
Szczech, LA	1
Best, B; Diamond, C; Goicoechea, M; Haubrich, R; Jain, S; Kemper, C; Liu, S; Louie, S; Sun, S; Witt, M	1
Atta, MG; Fine, DM; Lucas, GM; Perazella, MA	1

Reviews

28 review(s) available for tenofovir and Kidney Diseases

Article	Year
Tenofovir-induced renal and bone toxicity: report of two cases and literature review. Revista do Instituto de Medicina Tropical de Sao Paulo, 2022, Volume: 64 Topics: Anti-HIV Agents; Female; Hepatitis B; HIV Infections; Humans; Kidney; Kidney Diseases; Middle Aged; Tenofovir	2022
Potential kidney toxicity from the antiviral drug tenofovir: new indications, new formulations, and a new prodrug. Current opinion in nephrology and hypertension, 2018, Volume: 27, Issue:2 Topics: Adenine; Alanine; Antiviral Agents; Bone Density; Drug Interactions; Glomerular Filtration Rate; Hepatitis B; HIV Infections; Humans; Kidney Diseases; Pre-Exposure Prophylaxis; Prodrugs; Tenofovir	2018
Tenofovir-associated kidney disease in Africans: a systematic review. AIDS research and therapy, 2019, 06-06, Volume: 16, Issue:1 Topics: Africa; Anti-HIV Agents; HIV Infections; Humans; Kidney; Kidney Diseases; Renal Insufficiency; Tenofovir	2019
Antiretroviral therapy, immune suppression and renal impairment in HIV-positive persons. Current opinion in HIV and AIDS, 2014, Volume: 9, Issue:1 Topics: Adenine; Anti-Retroviral Agents; HIV Infections; Humans; Immunosuppression Therapy; Kidney Diseases; Organophosphonates; Protease Inhibitors; Tenofovir	2014
Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment. Journal of gastroenterology and hepatology, 2014, Volume: 29, Issue:3 Topics: Acidosis, Lactic; Adenine; Administration, Oral; Antiviral Agents; Arabinofuranosyluracil; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Humans; Kidney Diseases; Male; Muscular Diseases; Nervous System Diseases; Nucleosides; Nucleotides; Organophosphonates; Pharmacovigilance; Pregnancy; Telbivudine; Tenofovir; Thymidine	2014
Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention. European journal of clinical pharmacology, 2014, Volume: 70, Issue:9 Topics: Adenine; Animals; Anti-HIV Agents; HIV Infections; Humans; Incidence; Kidney Diseases; Organophosphonates; Reverse Transcriptase Inhibitors; Risk Factors; Tenofovir	2014
Renal and Bone Adverse Effects of a Tenofovir-Based Regimen in the Treatment of HIV-Infected Children: A Systematic Review. Drug safety, 2016, Volume: 39, Issue:3 Topics: Anti-HIV Agents; Bone Diseases; Child; HIV Infections; Humans; Kidney Diseases; Randomized Controlled Trials as Topic; Tenofovir; Treatment Outcome	2016
[Tenofovir nephrotoxicity]. Nephrologie & therapeutique, 2016, Volume: 12, Issue:3 Topics: Acute Disease; Chronic Disease; Humans; Incidence; Kidney Diseases; Practice Guidelines as Topic; Reverse Transcriptase Inhibitors; Risk Factors; Tenofovir	2016
Systematic review of renal and bone safety of the antiretroviral regimen efavirenz, emtricitabine, and tenofovir disoproxil fumarate in patients with HIV infection. HIV clinical trials, 2016, Volume: 17, Issue:6 Topics: Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Bone Diseases; Clinical Trials as Topic; Cyclopropanes; Drug Interactions; Emtricitabine; HIV Infections; Humans; Incidence; Kidney Diseases; Tenofovir; Treatment Outcome	2016
Managing chronic kidney disease in the older adults living with HIV. Current opinion in infectious diseases, 2017, Volume: 30, Issue:1 Topics: Adult; Aged; Anti-HIV Agents; Atazanavir Sulfate; Chronic Disease; Darunavir; Drug Substitution; HIV Infections; Humans; Kidney; Kidney Diseases; Lopinavir; Middle Aged; Tenofovir	2017
Kidney disease in patients with HIV infection and AIDS. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Dec-01, Volume: 47, Issue:11 Topics: Adenine; HIV Infections; Humans; Kidney Diseases; Organophosphonates; Risk Factors; Tenofovir	2008
[Tenofovir: pharmacology and interactions]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 8 Topics: Adenine; Adolescent; Adult; Aged; Anti-HIV Agents; Biological Availability; Biotransformation; Child; Child, Preschool; Deoxyadenine Nucleotides; DNA, Viral; Drug Interactions; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Kidney Diseases; Liver Diseases; Middle Aged; Molecular Structure; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Virus Replication; Young Adult	2008
[Clinical data II. Clinical experience of tenofovir DF in combination with protease inhibitors]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 8 Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Cohort Studies; Deoxycytidine; Diabetic Nephropathies; Double-Blind Method; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Emtricitabine; HIV; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; Humans; Kidney Diseases; Multicenter Studies as Topic; Organophosphonates; Randomized Controlled Trials as Topic; Retrospective Studies; Reverse Transcriptase Inhibitors; Salvage Therapy; Tenofovir; Treatment Outcome	2008
[Management of renal toxicity in HIV-positive patients. What to measure, how to measure it and how frequently]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 8 Topics: Adenine; Algorithms; Anti-HIV Agents; beta 2-Microglobulin; Clinical Trials as Topic; Cohort Studies; Creatinine; Drug Monitoring; Female; HIV Infections; Humans; Hypophosphatemia; Incidence; Kidney Diseases; Kidney Function Tests; Kidney Tubules; Male; Organophosphonates; Proteinuria; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors	2008
Pharmacogenetics of tenofovir treatment. Pharmacogenomics, 2009, Volume: 10, Issue:10 Topics: Adenine; Anti-HIV Agents; Anti-Retroviral Agents; HIV Infections; HIV-1; Humans; Kidney Diseases; Kidney Tubules; Multidrug Resistance-Associated Proteins; Organic Anion Transporters; Organophosphonates; Pharmacogenetics; Polymorphism, Genetic; Tenofovir	2009
Renal toxicity associated with tenofovir use. Expert opinion on drug safety, 2010, Volume: 9, Issue:4 Topics: Adenine; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Kidney; Kidney Diseases; Male; Mitochondria; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir	2010
Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Sep-01, Volume: 51, Issue:5 Topics: Adenine; Anti-HIV Agents; HIV Infections; Humans; Kidney Diseases; Organophosphonates; Tenofovir	2010
Renal disease associated with antiretroviral therapy in the treatment of HIV. Nephron. Clinical practice, 2011, Volume: 118, Issue:3 Topics: Adenine; Anti-Retroviral Agents; Atazanavir Sulfate; HIV Infections; Humans; Indinavir; Kidney Diseases; Oligopeptides; Organophosphonates; Pyridines; Tenofovir	2011
Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2011, Volume: 57, Issue:5 Topics: Adenine; Animals; Fanconi Syndrome; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Kidney Tubules, Proximal; Organophosphonates; Risk Factors; Tenofovir	2011
Novel nephrotoxins. Advances in chronic kidney disease, 2011, Volume: 18, Issue:3 Topics: Adenine; Alcohols; Angiogenesis Inhibitors; Anticonvulsants; Antipsychotic Agents; Dasatinib; Diphosphonates; Glutamates; Guanine; HIV Protease Inhibitors; Humans; Indoles; Kidney Diseases; Organophosphonates; Oxalates; Pamidronate; Pemetrexed; Phenindione; Plants, Toxic; Proton Pump Inhibitors; Pyrimidines; Pyrroles; Selective Serotonin Reuptake Inhibitors; Sunitinib; Tenofovir; Thiazoles; Triazines	2011
[Kidney and HIV infection]. Presse medicale (Paris, France : 1983), 2012, Volume: 41, Issue:3 Pt 1 Topics: Adenine; AIDS-Associated Nephropathy; Anti-HIV Agents; Biopsy; Black People; ErbB Receptors; Female; Genetic Predisposition to Disease; Glomerular Filtration Rate; HIV-1; Humans; Kidney; Kidney Diseases; Male; Organophosphonates; Phosphorus; Tenofovir; Virus Replication	2012
Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis. BMC public health, 2012, Mar-23, Volume: 12 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Anti-Retroviral Agents; Chronic Disease; Female; HIV Infections; Humans; Kidney Diseases; Male; Odds Ratio; Organophosphonates; Survival Rate; Tenofovir	2012
Update on tenofovir toxicity in the kidney. Pediatric nephrology (Berlin, Germany), 2013, Volume: 28, Issue:7 Topics: Adenine; Animals; Anti-HIV Agents; Antiviral Agents; Hepatitis B; HIV Infections; Humans; Kidney; Kidney Diseases; Organophosphonates; Risk Factors; Tenofovir	2013
Adverse effects of antiretroviral therapy for HIV infection: a review of selected topics. Expert opinion on drug safety, 2005, Volume: 4, Issue:2 Topics: Adenine; Alkynes; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cardiovascular Diseases; Cyclopropanes; Drug Monitoring; Drug Therapy, Combination; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Kidney Diseases; Lopinavir; Metabolic Syndrome; Nevirapine; Organophosphonates; Oxazines; Pyrimidinones; Risk Factors; Tenofovir	2005
[Renal toxicity in HIV-infected patients receiving HAART including tenofovir]. Le infezioni in medicina, 2006, Volume: 14, Issue:3 Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Interactions; HIV Infections; Humans; Kidney Diseases; Organophosphonates; Tenofovir	2006
Renal safety of tenofovir disoproxil fumarate. The AIDS reader, 2007, Volume: 17, Issue:2 Topics: Adenine; Anti-HIV Agents; Clinical Trials as Topic; HIV Infections; Humans; Kidney; Kidney Diseases; Organophosphonates; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Tenofovir	2007
HIV-1 infection and the kidney: an evolving challenge in HIV medicine. Mayo Clinic proceedings, 2007, Volume: 82, Issue:9 Topics: Acute Disease; Acute Kidney Injury; Adenine; AIDS-Associated Nephropathy; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Black or African American; Chronic Disease; Comorbidity; Disease Progression; HIV Infections; HIV-1; Humans; Kidney; Kidney Diseases; Kidney Failure, Chronic; Kidney Transplantation; Mice; Mice, Transgenic; Microcirculation; Organophosphonates; Tenofovir; Viral Proteins	2007
Kidney biopsy in HIV: beyond HIV-associated nephropathy. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2008, Volume: 51, Issue:3 Topics: Acute Disease; Adenine; AIDS-Associated Nephropathy; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biopsy; Comorbidity; Diabetic Nephropathies; Diagnosis, Differential; Female; HIV Infections; Humans; Hypertension; Immune Complex Diseases; Kidney; Kidney Diseases; Kidney Glomerulus; Middle Aged; Nephritis, Interstitial; Organophosphonates; Risk Assessment; Risk Factors; Tenofovir	2008

Trials

16 trial(s) available for tenofovir and Kidney Diseases

Article	Year
Early safety of tenofovir alafenamide in patients with a history of tubulopathy on tenofovir disoproxil fumarate: a randomized controlled clinical trial. HIV medicine, 2020, Volume: 21, Issue:3 Topics: Adenine; Alanine; Creatinine; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Kidney Tubules, Proximal; Linear Models; Male; Middle Aged; Retinol-Binding Proteins; Tenofovir; Treatment Outcome; United Kingdom	2020
Comparison of viral control between two tenofovir dose reduction regimens (300 mg every 48 hours versus 300 mg every 72 hours) in chronic hepatitis B patients with moderate renal impairment from tenofovir-induced renal dysfunction. Journal of viral hepatitis, 2021, Volume: 28, Issue:2 Topics: Antiviral Agents; Drug Tapering; Female; Hepatitis B, Chronic; Humans; Infant, Newborn; Kidney Diseases; Male; Tenofovir; Thailand	2021
Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial. BMC public health, 2017, Jul-04, Volume: 17, Issue:Suppl 3 Topics: Adult; Albuminuria; Anemia; Anti-HIV Agents; Antigens; CD4 Lymphocyte Count; Cities; Clinical Laboratory Techniques; Coinfection; Cost-Benefit Analysis; Creatinine; Female; Health Care Costs; Hemoglobins; Hepatitis B; HIV Infections; Humans; Kidney Diseases; Male; Mass Screening; Neutropenia; South Africa; Tenofovir; Transaminases	2017
Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals. Journal of acquired immune deficiency syndromes (1999), 2018, 06-01, Volume: 78, Issue:2 Topics: Adult; Albuminuria; Alpha-Globulins; Anti-HIV Agents; Biomarkers; Cross-Sectional Studies; Emtricitabine; Female; Glomerular Filtration Rate; HIV; HIV Infections; Humans; Kidney Diseases; Kidney Function Tests; Male; Pre-Exposure Prophylaxis; Proteinuria; Tenofovir; Transgender Persons; Urine; Young Adult	2018
Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study. BMC infectious diseases, 2013, Jul-01, Volume: 13 Topics: Adenine; Adult; Anti-HIV Agents; Creatinine; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Organophosphonates; Prospective Studies; Protease Inhibitors; Proteinuria; Ritonavir; Statistics, Nonparametric; Tenofovir	2013
Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine. AIDS (London, England), 2014, May-15, Volume: 28, Issue:8 Topics: Adenine; Adult; Antiviral Agents; Creatinine; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Kidney Diseases; Lopinavir; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Tenofovir; Treatment Outcome	2014
Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial. BMC pharmacology & toxicology, 2014, Dec-24, Volume: 15 Topics: Adenine; Adolescent; Adult; Alanine Transaminase; Anti-HIV Agents; Aspartate Aminotransferases; Black People; Chemical and Drug Induced Liver Injury; Creatinine; Deoxycytidine; Double-Blind Method; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Kidney Diseases; Organophosphonates; Phosphorus; Pre-Exposure Prophylaxis; Reverse Transcriptase Inhibitors; Tenofovir; Young Adult	2014
Tenofovir is associated with increased tubular proteinuria and asymptomatic renal tubular dysfunction in Ghana. BMC nephrology, 2015, Dec-01, Volume: 16 Topics: Adult; Anti-HIV Agents; Antiviral Agents; Causality; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Female; Ghana; HIV Infections; Humans; Kidney Diseases; Male; Middle Aged; Prevalence; Proteinuria; Risk Assessment; Tenofovir	2015
Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients. HIV medicine, 2011, Volume: 12, Issue:10 Topics: Adenine; Adult; Atazanavir Sulfate; Deoxycytidine; Drug Administration Schedule; Dyslipidemias; Emtricitabine; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Male; Oligopeptides; Organophosphonates; Pyridines; Saquinavir; Tenofovir; Treatment Outcome	2011
Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in Africa. Antiviral therapy, 2011, Volume: 16, Issue:7 Topics: Adenine; Adult; Africa; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Creatinine; Dideoxynucleosides; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Kidney Glomerulus; Lamivudine; Male; Nevirapine; Organophosphonates; Risk Factors; Tenofovir; Time Factors; Zidovudine	2011
Renal safety of tenofovir in HIV treatment-experienced patients. AIDS (London, England), 2004, Apr-30, Volume: 18, Issue:7 Topics: Adenine; Adult; Anti-HIV Agents; Double-Blind Method; Female; HIV Infections; Humans; Kidney Diseases; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir	2004
Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:4 Topics: Adenine; Adult; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Kidney Diseases; Male; Organophosphonates; Tenofovir; Time Factors	2005
Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Apr-15, Volume: 40, Issue:8 Topics: Adenine; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Creatinine; Female; HIV Infections; Humans; Kidney Diseases; Longitudinal Studies; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir	2005
Renal function in antiretroviral-experienced patients treated with tenofovir disoproxil fumarate associated with atazanavir/ritonavir. Antiviral therapy, 2007, Volume: 12, Issue:1 Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; CD4 Lymphocyte Count; Creatinine; Female; France; HIV Infections; HIV Protease Inhibitors; Humans; Kidney Diseases; Male; Middle Aged; Models, Biological; Oligopeptides; Organophosphonates; Prognosis; Prospective Studies; Pyridines; Reverse Transcriptase Inhibitors; Ritonavir; Tenofovir; Treatment Outcome	2007
Renal safety of tenofovir in HIV-infected children: a prospective, 96-week longitudinal study. Clinical drug investigation, 2007, Volume: 27, Issue:8 Topics: Adenine; Adolescent; Anti-HIV Agents; Child; Child, Preschool; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Male; Organophosphonates; Prospective Studies; Tenofovir	2007
Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy. The Journal of infectious diseases, 2008, Jan-01, Volume: 197, Issue:1 Topics: Adenine; Adult; Drug Therapy, Combination; Female; Glomerular Filtration Rate; HIV Infections; HIV Protease Inhibitors; Humans; Kidney Diseases; Kidney Tubules; Male; Middle Aged; Nucleosides; Organophosphonates; Prospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Time	2008

Other Studies

131 other study(ies) available for tenofovir and Kidney Diseases

Article	Year
Safety of Tenofovir Alafenamide in People With HIV Who Experienced Proximal Renal Tubulopathy on Tenofovir Disoproxil Fumarate. Journal of acquired immune deficiency syndromes (1999), 2021, 10-01, Volume: 88, Issue:2 Topics: Adenine; Adult; Alanine; Anti-HIV Agents; Creatinine; Cystatin C; Female; HIV Infections; Humans; Kidney Diseases; Kidney Tubules, Proximal; Male; Middle Aged; Tenofovir	2021
Renal safety of tenofovir disoproxil fumarate and entecavir in liver transplant patients: a nationwide Korean registry study. Hepatology international, 2022, Volume: 16, Issue:3 Topics: Adult; Antiviral Agents; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kidney; Kidney Diseases; Liver Transplantation; Registries; Republic of Korea; Retrospective Studies; Tenofovir; Treatment Outcome	2022
Renal Dysfunction due to Tenofovir-Diphosphate Inhibition of Mitochondrial Complex V (ATP Synthase). Function (Oxford, England), 2023, Volume: 4, Issue:3 Topics: Adenosine Triphosphate; Diphosphates; Humans; Kidney Diseases; Tenofovir	2023
Are Standard Doses of Renally-Excreted Antiretrovirals in Older Patients Appropriate: A PBPK Study Comparing Exposures in the Elderly Population With Those in Renal Impairment. Drugs in R&D, 2019, Volume: 19, Issue:4 Topics: Adult; Aged; Aging; Anti-HIV Agents; Area Under Curve; Dose-Response Relationship, Drug; Emtricitabine; Humans; Kidney Diseases; Kidney Function Tests; Lamivudine; Middle Aged; Models, Biological; Predictive Value of Tests; Tenofovir; Young Adult	2019
Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patients. The pharmacogenomics journal, 2020, Volume: 20, Issue:2 Topics: Adult; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B; Cohort Studies; Creatinine; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Logistic Models; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Phosphates; Polymorphism, Single Nucleotide; Receptors, Calcitriol; Retinol-Binding Proteins; Tenofovir; Vitamin D3 24-Hydroxylase	2020
To Study the Incidence of Tenofovir Related Nephropathies in HIV Infected Patients. The Journal of the Association of Physicians of India, 2020, Volume: 68, Issue:1 Topics: Anti-HIV Agents; HIV Infections; Humans; Incidence; Kidney Diseases; Tenofovir	2020
[Low Body Mass Index and impact of antiretroviral therapy on nephrotoxicity, chronic renal disease among HIV-infected patients in Brazzaville, Congo]. Nephrologie & therapeutique, 2020, Volume: 16, Issue:2 Topics: Adult; Antiviral Agents; Body Mass Index; Cohort Studies; Congo; Female; HIV Infections; Humans; Incidence; Kidney Diseases; Male; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Tenofovir	2020
Do genetic variations in proximal tubule transporters influence tenofovir-induced renal dysfunction? An exploratory study in a Ghanaian population. The Journal of antimicrobial chemotherapy, 2020, 05-01, Volume: 75, Issue:5 Topics: Anti-HIV Agents; Ghana; HIV Infections; Humans; Kidney Diseases; Multidrug Resistance-Associated Protein 2; Polymorphism, Single Nucleotide; Tenofovir	2020
HIV protease inhibitor ritonavir induces renal fibrosis and dysfunction: role of platelet-derived TGF-β1 and intervention via antioxidant pathways. AIDS (London, England), 2020, 06-01, Volume: 34, Issue:7 Topics: Animals; Antioxidants; Blood Platelets; Fibrosis; Heme Oxygenase-1; HIV Infections; HIV Protease Inhibitors; Kidney Diseases; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Rats; Ritonavir; Tenofovir; Transforming Growth Factor beta1	2020
Brief Report: Switching From TDF to TAF in HIV/HBV-Coinfected Individuals With Renal Dysfunction-A Prospective Cohort Study. Journal of acquired immune deficiency syndromes (1999), 2020, 10-01, Volume: 85, Issue:2 Topics: Adenine; Aged; Alanine; Anti-HIV Agents; Female; Glomerular Filtration Rate; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Interrupted Time Series Analysis; Kidney Diseases; Kidney Function Tests; Liver; Male; Middle Aged; Prospective Studies; Tenofovir; Viral Load	2020
Design and methods of the prevalence and pharmacogenomics of tenofovir nephrotoxicity in HIV-positive adults in south-western Nigeria study. BMC nephrology, 2020, 10-16, Volume: 21, Issue:1 Topics: Adult; Anti-HIV Agents; Black People; Case-Control Studies; Cross-Sectional Studies; Female; HIV Seropositivity; HIV-1; HIV-2; Humans; Kidney Diseases; Kidney Tubules; Male; Nigeria; Pharmacogenomic Testing; Polymorphism, Single Nucleotide; Prevalence; Research Design; Risk Factors; Socioeconomic Factors; Tenofovir; Viral Load	2020
Is urinary β2-microglobulin a reliable marker for assessment of renal tubular dysfunction in chronic hepatitis B patients receiving tenofovir therapy? European journal of gastroenterology & hepatology, 2021, 12-01, Volume: 33, Issue:1S Suppl 1 Topics: Adult; Antiviral Agents; Biomarkers; Creatinine; Glomerular Filtration Rate; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Kidney Diseases; Male; Tenofovir	2021
Tenofovir disoproxil fumarate-associated renal tubular dysfunction: noninvasive assessment of mitochondrial injury. AIDS (London, England), 2017, 06-01, Volume: 31, Issue:9 Topics: Adult; Aged; Anti-HIV Agents; Cross-Sectional Studies; DNA, Mitochondrial; Female; HIV Infections; Humans; Kidney Diseases; Kidney Tubules; Male; Middle Aged; Mitochondria; Mutation; Polymerase Chain Reaction; Tenofovir	2017
Tenofovir and adefovir down-regulate mitochondrial chaperone TRAP1 and succinate dehydrogenase subunit B to metabolically reprogram glucose metabolism and induce nephrotoxicity. Scientific reports, 2017, 04-11, Volume: 7 Topics: Adenine; Animals; Anti-HIV Agents; Cell Line; Cell Proliferation; Cell Survival; Glucose; Glycolysis; HSP90 Heat-Shock Proteins; Humans; Kidney Diseases; Mice; Mitochondria; Models, Biological; Organophosphonates; Proteome; Proteomics; Succinate Dehydrogenase; Tenofovir	2017
Changes in estimated glomerular filtration rate over time in South African HIV-1-infected patients receiving tenofovir: a retrospective cohort study. Journal of the International AIDS Society, 2017, Apr-10, Volume: 20, Issue:1 Topics: Adult; Anti-HIV Agents; Black People; CD4 Lymphocyte Count; Cohort Studies; Female; Glomerular Filtration Rate; HIV Infections; HIV-1; Humans; Incidence; Kidney Diseases; Male; Retrospective Studies; Risk Factors; South Africa; Tenofovir	2017
Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients. BMC infectious diseases, 2017, 06-05, Volume: 17, Issue:1 Topics: Adult; Alleles; Anti-HIV Agents; Cohort Studies; Female; HIV Infections; Humans; Kidney Diseases; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Polymorphism, Single Nucleotide; Proteinuria; Tenofovir	2017
Improvement in renal function and resolution of proteinuria in an HIV-infected patient switched from tenofovir disoproxil fumarate to tenofovir alafenamide. Internal medicine journal, 2017, Volume: 47, Issue:7 Topics: Adenine; Alanine; Antiviral Agents; Drug Substitution; Female; HIV Infections; Humans; Kidney Diseases; Middle Aged; Proteinuria; Tenofovir	2017
Incidence of renal Fanconi syndrome in patients taking antiretroviral therapy including tenofovir disoproxil fumarate. International journal of STD & AIDS, 2018, Volume: 29, Issue:3 Topics: Adult; Anti-HIV Agents; Australia; Creatinine; Fanconi Syndrome; HIV Infections; Humans; Incidence; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Proteinuria; Renal Insufficiency, Chronic; Tenofovir	2018
Tenofovir alafenamide nephrotoxicity in an HIV-positive patient: A case report. Medicine, 2017, Volume: 96, Issue:36 Topics: Adenine; Alanine; Anti-HIV Agents; HIV Infections; Humans; Kidney Diseases; Male; Middle Aged; Mitochondria; Prodrugs; Tenofovir	2017
Reversal of tenofovir induced nephrotoxicity: case reports of two patients. The Pan African medical journal, 2017, Volume: 27 Topics: Anti-HIV Agents; Creatinine; Humans; Kidney Diseases; Male; Middle Aged; Tenofovir	2017
Cumulative exposure of TDF is associated with kidney tubulopathy whether it is currently used or discontinued. AIDS (London, England), 2018, Jan-14, Volume: 32, Issue:2 Topics: Adult; Cross-Sectional Studies; Female; HIV Infections; Humans; Kidney Diseases; Kidney Function Tests; Kidney Tubules; Male; Middle Aged; Prospective Studies; Tenofovir	2018
[Nephrotoxicity of antiretrovirals other than tenofovir]. Nephrologie & therapeutique, 2018, Volume: 14, Issue:1 Topics: HIV Infections; Humans; Kidney; Kidney Diseases; Reverse Transcriptase Inhibitors; Tenofovir	2018
Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV positive adults in Ghana. The Journal of infection, 2018, Volume: 76, Issue:6 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Coinfection; Female; Ghana; Glomerular Filtration Rate; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Proteinuria; Tenofovir; Time Factors	2018
Efficacy of single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide in the treatment of HIV-1. Expert opinion on pharmacotherapy, 2018, Volume: 19, Issue:8 Topics: Adenine; Alanine; Anti-HIV Agents; Clinical Trials as Topic; Cobicistat; Darunavir; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; HIV Infections; Humans; Kidney Diseases; Tablets; Tenofovir	2018
Risk factors for kidney disease among HIV-1 positive persons in the methadone program. Clinical and experimental nephrology, 2019, Volume: 23, Issue:3 Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Drug Therapy, Combination; Female; Glomerular Filtration Rate; HIV Infections; Humans; Indinavir; Kidney Diseases; Male; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Poland; Risk Factors; Sex Factors; Tenofovir; Time Factors	2019
Management of Renal Disease: utility of a joint HIV-renal clinic. HIV medicine, 2019, Volume: 20, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Female; HIV Infections; Humans; Incidence; Interdisciplinary Communication; Kidney Diseases; Male; Middle Aged; Tenofovir; United Kingdom	2019
Mitochondrial pathway of apoptosis and necrosis contribute to tenofovir disoproxil fumarate-induced renal damage in rats. Human & experimental toxicology, 2019, Volume: 38, Issue:3 Topics: Animals; Anti-HIV Agents; Apoptosis; Cytochromes c; Kidney; Kidney Diseases; Male; Mitochondria; Necrosis; Neutrophils; Peroxidase; Poly(ADP-ribose) Polymerases; Rats, Wistar; Tenofovir	2019
Improvement of bone mineral density and markers of proximal renal tubular function in chronic hepatitis B patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide. Journal of viral hepatitis, 2019, Volume: 26, Issue:5 Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Bone Density; Drug Substitution; Female; Glomerular Filtration Rate; Hepatitis B, Chronic; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Pelvic Bones; Phosphorous Acids; Prospective Studies; Spine; Tenofovir; Treatment Outcome; Young Adult	2019
Efficacy and Safety of Tenofovir Disoproxil Fumarate in Treatment-Naïve Patients with Chronic Hepatitis B in Korea. Digestive diseases and sciences, 2019, Volume: 64, Issue:7 Topics: Adult; Antiviral Agents; Female; Hepatitis B, Chronic; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Patient Safety; Prospective Studies; Republic of Korea; Retrospective Studies; Risk Assessment; Risk Factors; Sustained Virologic Response; Tenofovir; Time Factors; Treatment Outcome; Viral Load	2019
Discontinuation of tenofovir due to nephrotoxicity: insight into 12 years of clinical practice Przeglad epidemiologiczny, 2019, Volume: 73, Issue:2 Topics: Adult; Anti-Retroviral Agents; Female; Glomerular Filtration Rate; Hematuria; HIV Infections; Humans; Kidney Diseases; Male; Middle Aged; Proteinuria; Retrospective Studies; Tenofovir	2019
Urinary beta-2 microglobulin and alpha-1 microglobulin are useful screening markers for tenofovir-induced kidney tubulopathy in patients with HIV-1 infection: a diagnostic accuracy study. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Volume: 19, Issue:5 Topics: Adenine; Adult; Alpha-Globulins; Anti-Retroviral Agents; beta 2-Microglobulin; Biomarkers; Chi-Square Distribution; Female; HIV Infections; HIV-1; Humans; Kidney Diseases; Male; Middle Aged; Organophosphonates; Sensitivity and Specificity; Tenofovir	2013
Tenofovir disoproxil fumarate-associated nephrotoxicity in HIV-infected patients: a prospective controlled study. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2013, Volume: 96, Issue:4 Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Incidence; Kidney Diseases; Male; Organophosphonates; Prospective Studies; Tenofovir; Zidovudine	2013
Short communication: Interferon/ribavirin treatment for HCV is associated with the development of hypophosphatemia in HIV/hepatitis C virus-coinfected patients. AIDS research and human retroviruses, 2013, Volume: 29, Issue:9 Topics: Adenine; Adult; Anti-HIV Agents; Antiviral Agents; Coinfection; Drug Interactions; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Hypophosphatemia; Interferons; Kidney Diseases; Male; Middle Aged; Organophosphonates; Retrospective Studies; Ribavirin; Risk Factors; Tenofovir	2013
Tenofovir-related nephrotoxicity: an ongoing clinical challenge. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2013, Aug-01, Volume: 70, Issue:15 Topics: Adenine; Anti-HIV Agents; Female; HIV Infections; Humans; Kidney Diseases; Male; Middle Aged; Organophosphonates; Risk Factors; Tenofovir	2013
Evolution of glomerular filtration rate in HIV-infected, HIV-HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarate. Journal of viral hepatitis, 2013, Volume: 20, Issue:9 Topics: Adenine; Adult; Antiviral Agents; Coinfection; Female; Glomerular Filtration Rate; Hepatitis B, Chronic; HIV Infections; Humans; Kidney Diseases; Male; Middle Aged; Organophosphonates; Risk Factors; Tenofovir	2013
Safety and efficacy of tenofovir/emtricitabine or abacavir/lamivudine in combination with efavirenz in treatment naïve HIV patients: a 5 year retrospective observational cohort study. (the TOKEN Study). International journal of clinical practice, 2013, Volume: 67, Issue:9 Topics: Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Cardiovascular Diseases; CD4 Lymphocyte Count; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Combinations; Emtricitabine; Female; HIV Infections; Humans; Kidney Diseases; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir; Viral Load	2013
Evaluation of renal adverse effects of combination anti-retroviral therapy including tenofovir in HIV-infected patients. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2013, Volume: 16, Issue:3 Topics: Adenine; Adult; Aged; Anti-HIV Agents; Atazanavir Sulfate; CD4 Lymphocyte Count; Drug Combinations; Female; Glomerular Filtration Rate; HIV Infections; HIV Protease Inhibitors; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Oligopeptides; Organophosphonates; Pyridines; Retrospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Tenofovir	2013
Tenofovir-induced renal tubular dysfunction in vertically HIV-infected patients associated with polymorphisms in ABCC2, ABCC4 and ABCC10 genes. The Pediatric infectious disease journal, 2013, Volume: 32, Issue:10 Topics: Adenine; Anti-HIV Agents; Child; Female; HIV Infections; Humans; Kidney Diseases; Kidney Tubules; Male; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organophosphonates; Polymorphism, Single Nucleotide; Tenofovir; Young Adult	2013
Low prevalence of renal dysfunction in HIV-infected pregnant women: implications for guidelines for the prevention of mother-to-child transmission of HIV. Tropical medicine & international health : TM & IH, 2013, Volume: 18, Issue:11 Topics: Adenine; Adult; Age Factors; Anti-HIV Agents; CD4 Lymphocyte Count; Contraindications; Creatinine; Female; HIV; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Kidney Diseases; Male; Mothers; Organophosphonates; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Pregnant Women; Prevalence; South Africa; Tenofovir; Viral Load	2013
A clinical prediction score for targeted creatinine testing before initiating tenofovir-based antiretroviral treatment in Cambodia. Journal of acquired immune deficiency syndromes (1999), 2014, Apr-01, Volume: 65, Issue:4 Topics: Adenine; Adult; Anti-HIV Agents; Cambodia; Clinical Medicine; Creatinine; Cross-Sectional Studies; Decision Support Techniques; Female; HIV Infections; Humans; Kidney Diseases; Male; Metabolic Clearance Rate; Organophosphonates; Tenofovir	2014
Recurrent bone fractures due to tenofovir-induced renal phosphate wasting. Scandinavian journal of infectious diseases, 2014, Volume: 46, Issue:3 Topics: Adenine; Adult; Anti-HIV Agents; Fractures, Stress; HIV Infections; Humans; Kidney Diseases; Male; Organophosphonates; Phosphates; Radiography; Tenofovir; Whole Body Imaging	2014
Urine liver-type fatty acid-binding protein and kidney injury molecule-1 in HIV-infected patients receiving combined antiretroviral treatment based on tenofovir. AIDS research and human retroviruses, 2014, Volume: 30, Issue:4 Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cross-Sectional Studies; Fatty Acid-Binding Proteins; Female; Hepatitis A Virus Cellular Receptor 1; HIV Infections; Humans; Kidney Diseases; Male; Membrane Glycoproteins; Middle Aged; Organophosphonates; Receptors, Virus; Tenofovir	2014
Telaprevir therapy, renal impairment, and their effects on the pharmacokinetics of tenofovir in HIV/hepatitis C virus coinfected patients. AIDS (London, England), 2014, Jan-14, Volume: 28, Issue:2 Topics: Adenine; Adult; Antiviral Agents; Hepatitis C; HIV Infections; Humans; Kidney Diseases; Male; Oligopeptides; Organophosphonates; Tenofovir	2014
Long-term treatment with tenofovir: prevalence of kidney tubular dysfunction and its association with tenofovir plasma concentration. Antiviral therapy, 2014, Volume: 19, Issue:8 Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Comorbidity; Cross-Sectional Studies; Drug Monitoring; Female; HIV Infections; Humans; Kidney Diseases; Kidney Function Tests; Kidney Tubules; Male; Middle Aged; Netherlands; Organophosphonates; Prevalence; Tenofovir	2014
Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure. The Journal of infectious diseases, 2014, Aug-01, Volume: 210, Issue:3 Topics: Adenine; Adult; Anti-HIV Agents; Cohort Studies; Drug Administration Schedule; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Male; Middle Aged; Organophosphonates; Proportional Hazards Models; Tenofovir; Viral Load	2014
Fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in HIV-infected patients. PloS one, 2014, Volume: 9, Issue:3 Topics: Adenine; Adult; Anti-HIV Agents; Case-Control Studies; Creatinine; Fanconi Syndrome; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Organophosphonates; Prognosis; Prospective Studies; Risk Factors; Tenofovir	2014
Higher risk of renal impairment associated with tenofovir use amongst people living with HIV in India: a comparative cohort analysis between Western India and United Kingdom. BMC infectious diseases, 2014, Mar-29, Volume: 14 Topics: Adenine; Adult; Anti-HIV Agents; Cohort Studies; Female; HIV Infections; Humans; India; Kidney Diseases; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir; United Kingdom	2014
Tenofovir in HIV-infected children. Antiretroviral efficacy, but beware of adverse effects on bone and the kidneys. Prescrire international, 2014, Volume: 23, Issue:149 Topics: Adenine; Anti-HIV Agents; Bone Diseases; Child; Dose-Response Relationship, Drug; HIV Infections; Humans; Kidney Diseases; Medication Errors; Organophosphonates; Tenofovir	2014
Vitamin D deficiency aggravates nephrotoxicity, hypertension and dyslipidemia caused by tenofovir: role of oxidative stress and renin-angiotensin system. PloS one, 2014, Volume: 9, Issue:7 Topics: Animals; Anti-HIV Agents; Dyslipidemias; Hypertension; Kidney Diseases; Male; Oxidative Stress; Rats; Rats, Wistar; Receptors, Angiotensin; Renin-Angiotensin System; Sodium-Phosphate Cotransporter Proteins; Tenofovir; Up-Regulation; Vascular Resistance; Vitamin D Deficiency	2014
High prevalence of signs of renal damage despite normal renal function in a cohort of HIV-infected patients: evaluation of associated factors. AIDS patient care and STDs, 2014, Volume: 28, Issue:10 Topics: Adenine; Adult; Age Factors; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Cross-Sectional Studies; Diabetes Mellitus; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Prevalence; Prospective Studies; Risk Factors; Socioeconomic Factors; Spain; Surveys and Questionnaires; Tenofovir; Viral Load	2014
Long term reference change value of creatinine in HIV-positive patients with anti-retroviral therapy: A new tool in clinical practice. Clinical biochemistry, 2015, Volume: 48, Issue:9 Topics: Adult; Anti-HIV Agents; Biomarkers, Pharmacological; Creatinine; Drug Monitoring; Female; HIV Infections; Humans; Kidney Diseases; Longitudinal Studies; Male; Middle Aged; Reference Values; Ritonavir; Tenofovir	2015
Renal tubular dysfunction associated with tenofovir therapy. The Journal of the Association of Physicians of India, 2014, Volume: 62, Issue:7 Topics: Adenine; Adult; Anti-HIV Agents; Creatinine; Developing Countries; Diagnosis, Differential; Female; HIV Infections; Humans; Incidence; India; Kidney Diseases; Kidney Tubules; Long-Term Care; Male; Middle Aged; Organophosphonates; Tenofovir	2014
Proximal tubular dysfunction in a HIV-1 patient with coadministered tenofovir disoproxil-fumarate and ibuprofen. AIDS (London, England), 2015, Mar-27, Volume: 29, Issue:6 Topics: Anti-HIV Agents; Anti-Inflammatory Agents, Non-Steroidal; HIV Infections; HIV-1; Humans; Ibuprofen; Kidney Diseases; Kidney Tubules, Proximal; Male; Middle Aged; Tenofovir	2015
Tenofovir-Associated Nephrotoxicity in Children with Perinatally-Acquired HIV Infection: A Single-Centre Cohort Study. Clinical drug investigation, 2015, Volume: 35, Issue:5 Topics: Adolescent; Anti-HIV Agents; Child; Female; HIV Infections; Humans; Hypokalemia; Hypophosphatemia; Kidney Diseases; Male; Retrospective Studies; Tenofovir	2015
Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2016, Volume: 22, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Drug-Related Side Effects and Adverse Reactions; Female; Glomerular Filtration Rate; Guanine; Hepatitis B, Chronic; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Retrospective Studies; Telbivudine; Tenofovir; Thymidine; Treatment Outcome	2016
Drug Transporter Genetic Variants Are Not Associated with TDF-Related Renal Dysfunction in Patients with HIV-1 Infection: A Pharmacogenetic Study. PloS one, 2015, Volume: 10, Issue:11 Topics: Adult; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B; Female; Genetic Variation; Genotype; Glomerular Filtration Rate; HIV Infections; HIV-1; Humans; Kidney Diseases; Logistic Models; Male; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Pharmacogenetics; Polymorphism, Single Nucleotide; Tenofovir	2015
Long-Term Follow-Up of Proteinuria and Estimated Glomerular Filtration Rate in HIV-Infected Patients with Tubular Proteinuria. PloS one, 2015, Volume: 10, Issue:11 Topics: Adult; Aged; Anti-HIV Agents; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Kidney Tubules; Longitudinal Studies; Male; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Proteinuria; Tenofovir; Time Factors; Viral Load	2015
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany. Digestive diseases and sciences, 2016, Volume: 61, Issue:10 Topics: Adult; Antiviral Agents; Creatinine; DNA, Viral; Elasticity Imaging Techniques; Fatigue; Female; Germany; Headache; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Kidney Diseases; Liver; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Tenofovir; Treatment Outcome; Viral Load	2016
Nephrotoxicity caused by oral antiviral agents in patients with chronic hepatitis B treated in a hospital for tropical diseases in Thailand. BMC pharmacology & toxicology, 2015, Dec-14, Volume: 16 Topics: Adenine; Adult; Antiviral Agents; Creatinine; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Hospitals; Humans; Incidence; Kidney Diseases; Lamivudine; Male; Middle Aged; Nephrons; Organophosphonates; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Telbivudine; Tenofovir; Thailand; Thymidine; Tropical Medicine	2015
The Epi-TAF for Tenofovir Disoproxil Fumarate? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, Apr-01, Volume: 62, Issue:7 Topics: Anti-HIV Agents; Bone Diseases; Cost-Benefit Analysis; HIV Infections; Humans; Kidney Diseases; Tenofovir; United States	2016
Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir. AIDS (London, England), 2016, Volume: 30, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; HIV Infections; Humans; Kidney Diseases; Kidney Function Tests; Kidney Tubules, Proximal; Male; Middle Aged; Prevalence; Prospective Studies; Tenofovir; Young Adult	2016
A Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 Infection. PloS one, 2016, Volume: 11, Issue:1 Topics: Adult; Antiretroviral Therapy, Highly Active; Female; Gene Frequency; Gene-Environment Interaction; Genotype; HIV Infections; Humans; Kidney Diseases; Lamivudine; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Nevirapine; Polymorphism, Single Nucleotide; Stavudine; Tenofovir; Thailand	2016
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France. Digestive diseases and sciences, 2016, Volume: 61, Issue:10 Topics: Abdominal Pain; Adult; Aged; Antiviral Agents; Asthenia; Diarrhea; DNA, Viral; Female; France; Headache; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Hypophosphatemia; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Nausea; Prospective Studies; Seroconversion; Tenofovir; Treatment Outcome; Viral Load; Vomiting	2016
Is Abnormal Urine Protein/Osmolality Ratio Associated with Abnormal Renal Function in Patients Receiving Tenofovir Disoproxil Fumarate? PloS one, 2016, Volume: 11, Issue:2 Topics: Adult; Anti-HIV Agents; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Osmolar Concentration; Proteinuria; Retrospective Studies; Tenofovir	2016
Bone mineral density decline according to renal tubular dysfunction and phosphaturia in tenofovir-exposed HIV-infected patients. AIDS (London, England), 2016, 06-01, Volume: 30, Issue:9 Topics: Absorptiometry, Photon; Adult; Aged; Anti-HIV Agents; Bone Density; Bone Resorption; Female; HIV Infections; Humans; Hypophosphatemia, Familial; Kidney Diseases; Longitudinal Studies; Male; Middle Aged; Tenofovir; Urinalysis	2016
Changes in Kidney Function and in the Rate of Tubular Dysfunction After Tenofovir Withdrawal or Continuation in HIV-Infected Patients. Journal of acquired immune deficiency syndromes (1999), 2016, 08-01, Volume: 72, Issue:4 Topics: Adult; Aged; Anti-HIV Agents; Female; Follow-Up Studies; Glomerular Filtration Rate; HIV Infections; Humans; Hypophosphatemia, Familial; Kidney Diseases; Kidney Function Tests; Kidney Tubules, Proximal; Male; Middle Aged; Prospective Studies; Tenofovir; Treatment Outcome; Young Adult	2016
Long-Term Efficacy of Tenofovir Disoproxil Fumarate Therapy in Nucleos(t)ide-Experienced Chronic Hepatitis B Patients. Clinical drug investigation, 2016, Volume: 36, Issue:6 Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Cohort Studies; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Kidney Diseases; Male; Middle Aged; Nucleotides; Retrospective Studies; Survival Analysis; Tenofovir; Treatment Outcome; Viral Load	2016
Risks and benefits HIV preexposure prophylaxis with tenofovir/emtricitabine in an older male with comorbidities. AIDS (London, England), 2016, 08-24, Volume: 30, Issue:13 Topics: Aged; Anti-HIV Agents; Chemoprevention; Comorbidity; Emtricitabine; HIV Infections; Humans; Kidney Diseases; Male; Pre-Exposure Prophylaxis; Risk Assessment; Tenofovir	2016
Renal Dysfunction during Tenofovir Use in a Regional Cohort of HIV-Infected Individuals in the Asia-Pacific. PloS one, 2016, Volume: 11, Issue:8 Topics: Adult; Anti-HIV Agents; Creatinine; Databases, Factual; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Poisson Distribution; Proportional Hazards Models; Prospective Studies; Risk Factors; Tenofovir	2016
Comparison of the effectiveness and renal safety of tenofovir versus entecavir in patients with chronic hepatitis B. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2016, Jun-01, Volume: 40, Issue:4 Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Tenofovir; Treatment Outcome	2016
[Changes in serum β2-microglobulin, retinol-binding protein, and cystatin C and their value in identifying early renal dysfunction in patients with chronic hepatitis B undergoing tenofovir or entecavir monotherapy: a comparative analysis]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2016, Sep-20, Volume: 24, Issue:9 Topics: Adult; Antiviral Agents; beta 2-Microglobulin; Creatinine; Cystatin C; Female; Guanine; Hepatitis B, Chronic; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Predictive Value of Tests; Renal Insufficiency; Retinol-Binding Proteins; Serum Albumin; Tenofovir; Treatment Outcome	2016
Role for NF-κB inflammatory signalling pathway in tenofovir disoproxil fumarate (TDF) induced renal damage in rats. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2017, Volume: 99 Topics: Animals; Anti-HIV Agents; Antioxidants; Blotting, Western; Cyclooxygenase 2; Enzyme-Linked Immunosorbent Assay; Immunoenzyme Techniques; Inflammation Mediators; Kidney Diseases; Male; Melatonin; NF-kappa B; Nitric Oxide Synthase Type II; Oxidative Stress; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Signal Transduction; Tenofovir; Tumor Necrosis Factor-alpha	2017
Real-World Assessment of Renal and Bone Safety among Patients with HIV Infection Exposed to Tenofovir Disoproxil Fumarate-Containing Single-Tablet Regimens. PloS one, 2016, Volume: 11, Issue:12 Topics: Adult; Antiretroviral Therapy, Highly Active; Bone Diseases; Comorbidity; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Population Surveillance; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Tablets; Tenofovir; United States	2016
Tenofovir-induced nephrotoxicity: A retrospective cohort study. The Medical journal of Malaysia, 2016, Volume: 71, Issue:6 Topics: Anti-HIV Agents; Cohort Studies; HIV Infections; Humans; Kidney Diseases; Malaysia; Retrospective Studies; Tenofovir	2016
Treatment-limiting renal tubulopathy in patients treated with tenofovir disoproxil fumarate. The Journal of infection, 2017, Volume: 74, Issue:5 Topics: Adult; Anti-HIV Agents; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Male; Middle Aged; Tenofovir	2017
Longitudinal Assessment of Proximal Tubular Dysfunction in HIV Seropositive and Seronegative Persons: Correlates and Implications. Journal of acquired immune deficiency syndromes (1999), 2017, 05-01, Volume: 75, Issue:1 Topics: Adult; Anti-HIV Agents; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Kidney Tubules, Proximal; Male; Middle Aged; Prospective Studies; Tenofovir	2017
Rosiglitazone reverses tenofovir-induced nephrotoxicity. Kidney international, 2008, Volume: 74, Issue:7 Topics: Adenine; Animals; Drug-Related Side Effects and Adverse Reactions; Glomerular Filtration Rate; Hypoglycemic Agents; Hypophosphatemia; Hypophosphatemia, Familial; Kidney Diseases; Male; Membrane Transport Proteins; Organophosphonates; Rats; Rats, Wistar; Reverse Transcriptase Inhibitors; Rosiglitazone; Tenofovir; Thiazolidinediones	2008
Tenofovir-associated decline in renal function. The Journal of infectious diseases, 2008, Sep-15, Volume: 198, Issue:6 Topics: Adenine; Adult; Anti-HIV Agents; Female; Glomerular Filtration Rate; HIV Infections; HIV Protease Inhibitors; Humans; Kidney; Kidney Diseases; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir	2008
[Conclusions. Tenofovir]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 8 Topics: Adenine; Anti-HIV Agents; Drug Resistance, Viral; HIV; HIV Infections; HIV Reverse Transcriptase; Humans; Kidney Diseases; Liver Diseases; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir	2008
Progressive renal tubular dysfunction associated with long-term use of tenofovir DF. AIDS research and human retroviruses, 2009, Volume: 25, Issue:4 Topics: Adenine; Adult; Aged; Anti-HIV Agents; Drug Therapy, Combination; Glomerular Filtration Rate; HIV Infections; HIV-1; Humans; Kidney Diseases; Kidney Tubules, Proximal; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors; Urinalysis; Young Adult	2009
[Renal tuberculosis and human immunodeficiency virus infection]. Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:6 Topics: Acute Kidney Injury; Adenine; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Fatal Outcome; Humans; Kidney Diseases; Male; Middle Aged; Multiple Organ Failure; Organophosphonates; Pneumocystis carinii; Pneumonia, Pneumocystis; Recurrence; Renal Dialysis; Tenofovir; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Renal	2009
Tenofovir-associated renal and bone toxicity. HIV medicine, 2009, Volume: 10, Issue:8 Topics: Adenine; Adult; Anti-HIV Agents; Creatinine; Fanconi Syndrome; Female; Glycosuria; HIV Infections; Humans; Kidney Diseases; Kidney Function Tests; Kidney Tubules, Proximal; Male; Mass Screening; Middle Aged; Organophosphonates; Osteomalacia; Proteinuria; Radionuclide Imaging; Tenofovir	2009
Renal function in patients with preexisting renal disease receiving tenofovir-containing highly active antiretroviral therapy in the HIV outpatient study. AIDS patient care and STDs, 2009, Volume: 23, Issue:8 Topics: Adenine; Adult; Aged; Ambulatory Care Facilities; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; United States	2009
HIV therapy may be given safely in resource-limited settings without routine laboratory monitoring. AIDS patient care and STDs, 2009, Volume: 23, Issue:8 Topics: Adenine; Anti-HIV Agents; Diagnostic Tests, Routine; Glomerular Filtration Rate; Health Resources; HIV Infections; HIV-1; Humans; Incidence; Kidney Diseases; Laboratories; Organophosphonates; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Uganda; Zimbabwe	2009
Renal function with use of a tenofovir-containing initial antiretroviral regimen. AIDS (London, England), 2009, Sep-24, Volume: 23, Issue:15 Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; Glomerular Filtration Rate; HIV Infections; HIV Protease Inhibitors; Humans; Kidney Diseases; Longitudinal Studies; Male; Organophosphonates; Prospective Studies; Reverse Transcriptase Inhibitors; Tenofovir	2009
The case: 41-year-old HIV patient with proteinuria and progressive renal dysfunction. Tenofovir toxicity. Kidney international, 2010, Volume: 77, Issue:5 Topics: Adenine; Adult; Anti-HIV Agents; Biopsy; Disease Progression; Humans; Kidney; Kidney Diseases; Kidney Tubules, Proximal; Male; Organophosphonates; Proteinuria; Tenofovir	2010
Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men. Journal of acquired immune deficiency syndromes (1999), 2010, Volume: 55, Issue:1 Topics: Adenine; Anti-HIV Agents; Glomerular Filtration Rate; HIV Infections; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Organophosphonates; Tenofovir; Withholding Treatment	2010
Tenofovir and changes in renal function. AIDS (London, England), 2010, Feb-20, Volume: 24, Issue:4 Topics: Adenine; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir	2010
Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations. AIDS (London, England), 2010, Apr-24, Volume: 24, Issue:7 Topics: Adenine; HIV Infections; Humans; Kidney Diseases; Kidney Function Tests; Kidney Tubules; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir	2010
Prevalence and factors associated with renal dysfunction among HIV-infected patients. AIDS patient care and STDs, 2010, Volume: 24, Issue:6 Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cross-Sectional Studies; Female; Glomerular Filtration Rate; HIV Infections; HIV-1; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Military Hygiene; Military Personnel; Organophosphonates; Prevalence; Reverse Transcriptase Inhibitors; Risk Factors; Tenofovir; Time Factors	2010
Prospective study of renal function in HIV-infected pediatric patients receiving tenofovir-containing HAART regimens. AIDS (London, England), 2011, Jan-14, Volume: 25, Issue:2 Topics: Adenine; Adolescent; Antiretroviral Therapy, Highly Active; Child; Female; HIV Infections; Humans; Kidney Diseases; Kidney Function Tests; Male; Organophosphonates; Prospective Studies; Proteinuria; Spain; Tenofovir	2011
Is tenofovir-related renal toxicity incompletely reversible? Journal of acquired immune deficiency syndromes (1999), 2011, Mar-01, Volume: 56, Issue:3 Topics: Adenine; Adult; Anti-HIV Agents; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Male; Middle Aged; Organophosphonates; Tenofovir	2011
Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naïve patients. Scandinavian journal of infectious diseases, 2011, Volume: 43, Issue:8 Topics: Adenine; Adult; Anti-HIV Agents; Cohort Studies; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Tenofovir	2011
Improvement in chronic renal impairment following the discontinuation of tenofovir in two HIV-infected patients. Nephrology (Carlton, Vic.), 2011, Volume: 16, Issue:4 Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biomarkers; Biopsy; Chronic Disease; Creatinine; Drug Substitution; Glomerular Filtration Rate; HIV Infections; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir	2011
Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction. The Journal of infectious diseases, 2011, Jul-01, Volume: 204, Issue:1 Topics: Adenine; Anti-HIV Agents; Female; HIV Infections; Humans; Kidney; Kidney Diseases; Kidney Tubules; Male; Multidrug Resistance-Associated Proteins; Organophosphonates; Polymorphism, Single Nucleotide; Tenofovir	2011
Determination of kidney function before tenofovir initiation: four-fold difference in need of tenofovir dose reduction depending on method used. Journal of acquired immune deficiency syndromes (1999), 2011, Jun-01, Volume: 57, Issue:2 Topics: Adenine; Adult; Anti-HIV Agents; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Male; Organophosphonates; Retrospective Studies; Tenofovir	2011
Assessing recovery of renal function after tenofovir disoproxil fumarate discontinuation. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012, Volume: 18, Issue:2 Topics: Adenine; Adolescent; Adult; Aged; Anti-HIV Agents; Drug Administration Schedule; Female; Glomerular Filtration Rate; HIV Infections; Humans; Japan; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Young Adult	2012
Tenofovir induced acute kidney injury in a patient with unilateral renal agenesis despite initially non-impaired renal function. European journal of medical research, 2011, Dec-02, Volume: 16, Issue:12 Topics: Acute Kidney Injury; Adenine; Adult; Anti-HIV Agents; Congenital Abnormalities; HIV Infections; Humans; Kidney; Kidney Diseases; Male; Organophosphonates; Tenofovir	2011
Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir. AIDS patient care and STDs, 2012, Volume: 26, Issue:1 Topics: Adenine; Anti-HIV Agents; Biomarkers; Cohort Studies; Cytochromes c; Deoxycytidine; Dideoxynucleosides; Drug Combinations; Emtricitabine; Female; Glomerular Filtration Rate; Glutathione Transferase; HIV Infections; Humans; Kidney Diseases; Kidney Tubules, Proximal; Lamivudine; Male; Middle Aged; Mitochondria; Organophosphonates; Tenofovir; Time Factors	2012
Tenofovir-induced nephrotoxicity: myths and facts. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2012, Volume: 23, Issue:1 Topics: Adenine; Animals; Anti-HIV Agents; Evidence-Based Medicine; HIV Infections; HIV-1; Humans; Kidney Diseases; Organophosphonates; Reverse Transcriptase Inhibitors; Risk Factors; Tenofovir	2012
Renal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate and protease inhibitors. BMC infectious diseases, 2012, Jan-23, Volume: 12 Topics: Adenine; Adolescent; Anti-HIV Agents; Child; Female; HIV Infections; HIV Protease Inhibitors; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Organophosphonates; Prospective Studies; Tenofovir	2012
Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2012, Volume: 10, Issue:8 Topics: Adenine; Adult; Aged; Antiviral Agents; Cohort Studies; Creatinine; Female; Glomerular Filtration Rate; Guanine; Hepatitis B, Chronic; Humans; Kidney Diseases; Male; Middle Aged; Organophosphonates; Retrospective Studies; Risk Assessment; Tenofovir; Young Adult	2012
Lamivudine or emtricitabine (XTC)/protease inhibitor dual therapy as a harm-reduction strategy in patients with tenofovir-related renal toxicity: a case-control study. Scandinavian journal of infectious diseases, 2012, Volume: 44, Issue:11 Topics: Adenine; Adult; Aged; Case-Control Studies; CD4 Lymphocyte Count; Chi-Square Distribution; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Kidney Diseases; Kidney Function Tests; Lamivudine; Male; Middle Aged; Organophosphonates; Protease Inhibitors; Retrospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Viral Load	2012
High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy. Antiviral research, 2012, Volume: 96, Issue:1 Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Organophosphonates; Tenofovir; Time Factors; Withholding Treatment	2012
Single nucleotide polymorphisms in ABCC2 associate with tenofovir-induced kidney tubular dysfunction in Japanese patients with HIV-1 infection: a pharmacogenetic study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55, Issue:11 Topics: Adenine; Adult; Cohort Studies; Cross-Sectional Studies; Female; Genetic Predisposition to Disease; HIV Infections; HIV-1; Humans; Japan; Kidney Diseases; Kidney Tubules; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organophosphonates; Polymorphism, Single Nucleotide; Tenofovir	2012
Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir. Scandinavian journal of infectious diseases, 2013, Volume: 45, Issue:2 Topics: Adenine; Adult; Alkynes; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Deoxycytidine; Emtricitabine; Female; Glomerular Filtration Rate; Glycosuria; HIV Infections; HIV Protease Inhibitors; Humans; Kidney Diseases; Lopinavir; Male; Middle Aged; Oligopeptides; Organophosphonates; Proteinuria; Pyridines; Retrospective Studies; Ritonavir; Tenofovir	2013
Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 56, Issue:4 Topics: Adenine; Adult; Anti-HIV Agents; Canada; Cohort Studies; Female; Follow-Up Studies; Glomerular Filtration Rate; HIV Infections; HIV Seropositivity; Humans; Kidney Diseases; Male; Organophosphonates; Proportional Hazards Models; Tenofovir	2013
Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2012, Volume: 26, Issue:12 Topics: Adenine; Allied Health Personnel; Antibodies, Viral; Antiviral Agents; Canada; Coinfection; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Humans; Interferons; Kidney Diseases; Liver; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir	2012
Rapid communication: acute renal failure associated with tenofovir: evidence of drug-induced nephrotoxicity. The American journal of the medical sciences, 2002, Volume: 324, Issue:6 Topics: Acute Kidney Injury; Adenine; Adult; Anti-HIV Agents; Chronic Disease; HIV Infections; Humans; Kidney; Kidney Diseases; Male; Organophosphonates; Organophosphorus Compounds; Tenofovir	2002
Tenofovir disoproxil fumarate. Drugs, 2003, Volume: 63, Issue:15 Topics: Adenine; Anti-HIV Agents; Drug Administration Schedule; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Kidney Diseases; Mutation; Organophosphonates; Organophosphorus Compounds; Tenofovir; Time Factors	2003
Didanosine-associated toxicity: a predictable complication of therapy with tenofovir and didanosine? Journal of acquired immune deficiency syndromes (1999), 2004, Apr-01, Volume: 35, Issue:4 Topics: Adenine; Adult; Anti-HIV Agents; Creatinine; Didanosine; Drug Interactions; Drug Therapy, Combination; Female; HIV Infections; Humans; Kidney Diseases; Male; Middle Aged; Organophosphonates; Tenofovir	2004
Proximal tubular kidney damage and tenofovir: a role for mitochondrial toxicity? AIDS (London, England), 2004, Aug-20, Volume: 18, Issue:12 Topics: Adenine; Adult; Anti-HIV Agents; DNA, Mitochondrial; HIV Infections; HIV-1; Humans; Kidney Diseases; Kidney Tubules, Proximal; Male; Organophosphonates; Organophosphorus Compounds; Tenofovir	2004
Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure. The American journal of medicine, 2004, Aug-15, Volume: 117, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Fanconi Syndrome; Humans; Kidney Diseases; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Renal Insufficiency; Tenofovir	2004
Antiretroviral therapy with tenofovir is associated with mild renal dysfunction. AIDS (London, England), 2005, Jan-03, Volume: 19, Issue:1 Topics: Adenine; Anti-HIV Agents; Creatinine; Cross-Sectional Studies; Cystatin C; Cystatins; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Organophosphonates; Proteinuria; Tenofovir	2005
Tenofovir and renal toxicity. AIDS patient care and STDs, 2004, Volume: 18, Issue:10 Topics: Adenine; Anti-HIV Agents; Creatinine; Humans; Kidney Diseases; Organophosphonates; Tenofovir; Viral Load	2004
Incidence of and risk factors for tenofovir-induced nephrotoxicity: a retrospective cohort study. HIV medicine, 2005, Volume: 6, Issue:4 Topics: Adenine; Adult; Anti-HIV Agents; Creatinine; Female; HIV Infections; Humans; Hypophosphatemia; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Organophosphonates; Proteinuria; Retrospective Studies; Risk Factors; Tenofovir; Urinalysis	2005
Tenofovir and changes in renal function. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Aug-15, Volume: 41, Issue:4 Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; HIV Infections; Humans; Kidney Diseases; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir	2005
Progression of renal impairment under therapy with tenofovir. AIDS (London, England), 2005, Aug-12, Volume: 19, Issue:12 Topics: Adenine; Anti-HIV Agents; Case-Control Studies; Disease Progression; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; Tenofovir	2005
Low frequency of renal function impairment during one-year of therapy with tenofovir-containing regimens in the real-world: a case-control study. AIDS patient care and STDs, 2005, Volume: 19, Issue:7 Topics: Adenine; Antiretroviral Therapy, Highly Active; Case-Control Studies; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; HIV Infections; Humans; Incidence; Kidney; Kidney Diseases; Kidney Function Tests; Male; Organophosphonates; Probability; Prognosis; Reference Values; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Assessment; Severity of Illness Index; Tenofovir	2005
Nephrotoxicity in a child with perinatal HIV on tenofovir, didanosine and lopinavir/ritonavir. Pediatric nephrology (Berlin, Germany), 2006, Volume: 21, Issue:7 Topics: Adenine; Anti-HIV Agents; Child; Diabetes Insipidus, Nephrogenic; Didanosine; Drug Therapy, Combination; Fanconi Syndrome; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Kidney; Kidney Diseases; Lopinavir; Organophosphonates; Pregnancy; Pregnancy Complications; Pyrimidinones; Ritonavir; Tenofovir	2006
Hypokalemia in HIV patients on tenofovir. AIDS (London, England), 2006, Aug-01, Volume: 20, Issue:12 Topics: Adenine; Adolescent; Adult; Body Weight; Child; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hypokalemia; Kidney Diseases; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Risk Factors; Ritonavir; Tenofovir; Time Factors	2006
Estimating renal function in patients on tenofovir disoproxil fumarate: suggestions for safer use. HIV medicine, 2006, Volume: 7, Issue:7 Topics: Adenine; Creatinine; Dose-Response Relationship, Drug; Fanconi Syndrome; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Organophosphonates; Osteomalacia; Reverse Transcriptase Inhibitors; Tenofovir	2006
HIV-associated nephropathy and drug-induced renal injury. MedGenMed : Medscape general medicine, 2006, Jun-08, Volume: 8, Issue:2 Topics: Adenine; AIDS-Associated Nephropathy; Anti-HIV Agents; Humans; Kidney Diseases; Male; Middle Aged; Organophosphonates; Tenofovir	2006
Antiviral therapy for pre- and post-liver transplantation patients with hepatitis B. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2007, Volume: 13, Issue:3 Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Humans; Kidney Diseases; Lamivudine; Liver Transplantation; Organophosphonates; Secondary Prevention; Tenofovir	2007
Editorial comment: tenofovir-related nephrotoxicity--who's at risk? The AIDS reader, 2007, Volume: 17, Issue:2 Topics: Adenine; Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Kidney Diseases; Organophosphonates; Reverse Transcriptase Inhibitors; Risk Factors; Tenofovir	2007
Tenofovir-induced kidney injury. Expert opinion on drug safety, 2007, Volume: 6, Issue:2 Topics: Adenine; Animals; Anti-HIV Agents; Humans; Kidney Diseases; Organophosphonates; Tenofovir	2007
The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years. AIDS (London, England), 2007, Jun-19, Volume: 21, Issue:10 Topics: Adenine; Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Anti-Retroviral Agents; Antiviral Agents; Body Weight; CD4 Lymphocyte Count; Creatinine; Drug Therapy, Combination; Female; HIV Infections; Humans; Kidney; Kidney Diseases; Male; Organophosphonates; Product Surveillance, Postmarketing; Reverse Transcriptase Inhibitors; Risk Factors; Tenofovir	2007
Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2008, Volume: 62, Issue:1 Topics: Adenine; Adult; Age Factors; Anti-HIV Agents; Cohort Studies; Comorbidity; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Italy; Kidney Diseases; Male; Middle Aged; Organophosphonates; Prevalence; Prospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Tenofovir	2008
Effect of tenofovir on renal glomerular and tubular function. AIDS (London, England), 2007, Jul-11, Volume: 21, Issue:11 Topics: Adenine; Anti-Retroviral Agents; Case-Control Studies; Cross-Sectional Studies; Glomerular Filtration Rate; HIV Infections; HIV-1; Humans; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir	2007
Is phosphatemia the best tool to monitor renal tenofovir toxicity? Journal of acquired immune deficiency syndromes (1999), 2007, Oct-01, Volume: 46, Issue:2 Topics: Adenine; Biomarkers; Creatinine; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Kidney Tubules; Organophosphonates; Phosphates; Tenofovir	2007
Tenofovir nephrotoxicity: focusing research questions and putting them into clinical context. The Journal of infectious diseases, 2008, Jan-01, Volume: 197, Issue:1 Topics: Adenine; HIV Infections; Humans; Kidney Diseases; Kidney Tubules; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir	2008